Sigma-1 Receptor Agonist Fluvoxamine Ameliorates Fibrotic Response of Trabecular Meshwork Cells

Judit Hodrea(Semmelweis University), Andrea Fekete(Semmelweis University)
International Journal of Molecular Sciences
July 19, 2023
10.3390/ijms241411646
Cited by 6

Related Papers

Reduced <i>O</i>-GlcNAcylation and tubular hypoxia contribute to the antifibrotic effect of SGLT2 inhibitor dapagliflozin in the diabetic kidney
|American Journal of Physiology-Renal Physiology|2020|51
Sigma-1 Receptor Activation Is Protective against TGFβ2-Induced Extracellular Matrix Changes in Human Trabecular Meshwork Cells
|Life|2023|7
The Sigma-1 Receptor Agonist Fluvoxamine Is Protective in Hyperglycaemia-Induced Dysfunction of Trabecular Meshwork Cells
|Pharmaceuticals|2026|0